These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 22952118

  • 1. CXCL1-deficient mice are highly sensitive to pseudomonas aeruginosa but not herpes simplex virus type 1 corneal infection.
    Bryant-Hudson KM, Carr DJ.
    Invest Ophthalmol Vis Sci; 2012 Oct 01; 53(11):6785-92. PubMed ID: 22952118
    [Abstract] [Full Text] [Related]

  • 2. Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis.
    Huang LC, Reins RY, Gallo RL, McDermott AM.
    Invest Ophthalmol Vis Sci; 2007 Oct 01; 48(10):4498-508. PubMed ID: 17898271
    [Abstract] [Full Text] [Related]

  • 3. Interferon regulatory factor-1 in flagellin-induced reprogramming: potential protective role of CXCL10 in cornea innate defense against Pseudomonas aeruginosa infection.
    Yoon GS, Dong C, Gao N, Kumar A, Standiford TJ, Yu FS.
    Invest Ophthalmol Vis Sci; 2013 Nov 15; 54(12):7510-21. PubMed ID: 24130180
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
    Hazlett LD, Rudner XL, McClellan SA, Barrett RP, Lighvani S.
    Invest Ophthalmol Vis Sci; 2002 Feb 15; 43(2):419-24. PubMed ID: 11818386
    [Abstract] [Full Text] [Related]

  • 9. CCR6-Positive γδ T Cells Provide Protection Against Intracorneal HSV-1 Infection.
    Fitzpatrick S, Lausch R, Barrington RA.
    Invest Ophthalmol Vis Sci; 2019 Sep 03; 60(12):3952-3962. PubMed ID: 31560369
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protective efficacy of a peptide derived from a potential adhesin of Pseudomonas aeruginosa against corneal infection.
    Yuan Q, Wu Y, Wang Y, Chen L, Qu M, Duan K, Zhao G.
    Exp Eye Res; 2016 Feb 03; 143():39-48. PubMed ID: 26500187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. VIP promotes resistance in the Pseudomonas aeruginosa-infected cornea by modulating adhesion molecule expression.
    Berger EA, McClellan SA, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2010 Nov 03; 51(11):5776-82. PubMed ID: 20592225
    [Abstract] [Full Text] [Related]

  • 18. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA, Zhang Y, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2008 Apr 03; 49(4):1502-11. PubMed ID: 18385069
    [Abstract] [Full Text] [Related]

  • 19. ISG15 Acts as a Mediator of Innate Immune Response to Pseudomonas aeruginosa Infection in C57BL/6J Mouse Corneas.
    Gao N, Me R, Dai C, Yu FX.
    Invest Ophthalmol Vis Sci; 2020 May 11; 61(5):26. PubMed ID: 32416603
    [Abstract] [Full Text] [Related]

  • 20. Contribution of the cornea to cytokine levels in the whole eye induced during the early phase of Pseudomonas aeruginosa challenge.
    Cole N, Hume E, Khan S, Madigan M, Husband AJ, Garthwaite L, Willcox M.
    Immunol Cell Biol; 2005 Jun 11; 83(3):301-6. PubMed ID: 15877609
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.